The EPS miss vs consensus is modest but may weigh on the stock near-term. However, FY27 guidance of 9-11% EPS growth and 6-7% organic revenue growth, plus the $1B buyback, provide a supportive floor. Watch the earnings call for commentary on tariff impacts and Healthcare segment margin trajectory.
Price Chart
Executive Summary
STERIS reported fiscal Q4 2026 adjusted EPS of $2.83, slightly above the $2.74 prior year but below the $2.85 consensus estimate. Revenue grew 7% to $1.6B, in line with the $1.6B consensus. The company guided fiscal 2027 adjusted EPS of $11.10-$11.30 (9-11% growth) and constant currency organic revenue growth of 6-7%, while announcing a new $1B share buyback program. The EPS miss relative to consensus and tariff/inflation headwinds are offset by solid revenue growth and positive guidance.
Key Financial Metrics
Key Facts
- Fiscal Q4 2026 adjusted EPS $2.83 vs consensus $2.85 (miss) and prior year $2.74
- Fiscal Q4 2026 revenue $1.6B, +7% YoY, in line with consensus
- Full year fiscal 2026 adjusted EPS $10.17, +10.3% YoY
- Full year fiscal 2026 revenue $5.9B, +9% YoY; constant currency organic growth 7%
- Fiscal 2027 guidance: adjusted EPS $11.10-$11.30 (9-11% growth), constant currency organic revenue growth 6-7%
- New $1B share repurchase program authorized
- Free cash flow fiscal 2026 $982.9M, up from $787.2M prior year
- Tariffs and inflation partially offset volume/price gains in Healthcare segment
Financial Impact
Q4 adjusted EPS $2.83 vs $2.85 consensus (-0.7% miss); revenue $1.6B in line; FY27 guidance implies ~$6.3B revenue and ~$11.20 EPS midpoint
Risk Factors
- Tariffs and inflation continue to pressure Healthcare segment margins
- Constant currency organic growth of 6-7% in FY27 is below FY26's 7% — potential deceleration
- Capital equipment revenue in AST declined 62% YoY in Q4, signaling lumpy demand
- Effective tax rate assumption of ~25% for FY27 could be a headwind if actual rate is higher
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3292377 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | Press Release | $230.34 $236.44 | ▲ +2.65% | ▼ −0.73% | $208.54 (−9.46%) |
Jun 15, 2026 15w ago | 144 | $206.51 $208.73 | ▲ +1.07% | ▲ +0.88% | $208.54 (+0.98%) |
Jun 11, 2026 16w ago | DEFA14A | $207.56 $216.00 | ▲ +4.07% | ▲ +2.29% | $208.54 (+0.47%) |
Jun 8, 2026 16w ago | Insider Cluster | $212.88 $215.39 | ▲ +1.18% | ▼ −0.27% | $208.54 (−2.04%) |
Jun 5, 2026 17w ago | 144 | $210.03 $213.28 | ▲ +1.55% | ▼ −0.08% | $208.54 (−0.71%) |
Jun 4, 2026 17w ago | 144 | $212.35 $213.28 | ▲ +0.44% | ▼ −1.42% | $208.54 (−1.79%) |
May 11, 2026 20w ago | 8-K | $210.23 $208.10 | ▲ +1.01% | ▼ −0.71% | $208.54 (+0.80%) |
May 11, 2026 20w ago | Press Release | $210.23 $208.10 | ▼ −1.01% | ▲ +0.71% | $208.54 (−0.80%) |
May 7, 2026 21w ago | 8-K | $207.24 $212.35 | ▲ +2.47% | ▲ +2.44% | $208.54 (+0.63%) |
Apr 21, 2026 23w ago | Press Release | $222.61 $214.42 | ▼ −3.68% | ▼ −6.84% | $208.54 (−6.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access